Profound Medical Corp. (PROF) Tops Q3 EPS by 8c

Profound Medical Corp. (NASDAQ: PROF) reported Q3 EPS of ($0.26), $0.08 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $2.17 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.

You May Also Be Interested In

• Arxis, Inc. (ARXS) Reports Q2 EPS of $0.28; offers guidance
• AB InBev SA (BUD) Tops Q2 EPS by 9c
• Sanofi (SNY) Tops Q2 EPS by 100c